Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring neurocognitive impairment in virally suppressed HIV: HIV-associated neurocognitive disorders, HIV-associated brain injury problems and solutions.

Current opinion in HIV and AIDS·2026
Same author

Integrating HIV services in an era of global change.

Journal of the International AIDS Society·2026
Same author

Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice.

PloS one·2025
Same author

Persistent cell-associated HIV-1 RNA in virally suppressed individuals on INSTI-based ART.

Journal of virus eradication·2025
Same author

Editorial: Viral impact on CNS: mechanisms of immune dysfunction and cognitive decline.

Frontiers in immunology·2025
Same author

Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches.

Current opinion in HIV and AIDS·2025

Related Experiment Video

Updated: May 15, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Is specific HIV eradication from the brain possible or needed?

Bruce J Brew1, Lachlan Gray, Sharon Lewin

  • 1St Vincent's Hospital, Darlinghurst, NSW, 2010, Australia. B.Brew@UNSW.edu.au

Expert Opinion on Biological Therapy
|January 8, 2013
PubMed
Summary

Eradicating human immunodeficiency virus (HIV) is a growing focus, but brain involvement presents significant challenges. More research is needed to identify patients requiring brain-specific HIV eradication and the best methods.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Experiment Videos

Last Updated: May 15, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Area of Science:

  • Neurovirology
  • Infectious Diseases
  • Immunology

Background:

  • Growing interest in HIV eradication strategies.
  • Brain involvement by HIV complicates systemic eradication efforts.
  • Recent case reports highlight the possibility of HIV eradication.

Purpose of the Study:

  • To review HIV latency mechanisms and eradication strategies.
  • To discuss the challenges posed by HIV brain disease.
  • To explore potential approaches to overcome these challenges.

Main Methods:

  • Literature review on HIV latency.
  • Analysis of current HIV eradication strategies.
  • Discussion of neuroinflammation and HIV reservoirs in the brain.

Main Results:

  • HIV latency mechanisms are complex and varied.
  • Multiple HIV eradication strategies are under investigation.
  • HIV brain disease presents unique challenges to eradication.

Conclusions:

  • Brain-specific HIV eradication may be necessary for a subset of patients.
  • Identifying patients who need brain-directed therapy requires further research.
  • Optimal methodologies for brain-targeted HIV eradication are yet to be determined.